P95 is a European small to medium-sized enterprise (SME) serving a global clientele through excellence in science. P95 is dedicated to healthcare research in the fields of pharmacovigilance, epidemiology and pharmaco-epidemiology.
P95 finds, collects, analyses and reports epidemiological data to assist public health agencies, research organisations and pharmaceutical companies in improving peoples’ access to safe and effective vaccines.
P95 was founded by Thomas Verstraeten in June 2011 and encompasses a team of epidemiologists, data scientists, medical writers, IT engineers, pharmacovigilance specialists, administrative staff, project managers and project support officers. The P95 team is an international team, based in many countries, including Belgium, the Netherlands, Spain, Italy, Colombia, the USA, and Australia.
Projects in which P95 is or has been involved span most areas of epidemiology and pharmacovigilance, including such activities as literature reviews, protocol development, study set-up, identification of investigators, statistical analyses, conference presentations, publication writing, process development, reviews of risk management plan, pharmacovigilance training and DSMB support.
Key areas of focus
Data Management – Early Clinical Phases – Late phase IV – Medical Writing – Pharmacovigilance & Drug – Preclinical – Project Management – Safety – Statistics